INTERAGENCY COMMITTEE ON RECOMBINANT DNA RESEARCH 
Minutes of Tenth Meeting 
July 17, 1979 
8:30 - 10:00 a.m. 
National Institutes of Health 
Bethesda, Maryland 20205 
The meeting, chaired by Dr. Donald S. Fredrickson, Director, National 
Institutes of Health, was devoted to (1) a review of the implementation 
of the revised NIH Guidelines, (2) an NIH proposal for extending the Guide- 
lines to private-sector research, and (3) agency discussion on this proposed 
approach and alternatives. (See list of attendees. Attachment A.) 
Implementation of the Revised NIH Guidelines: Status Report 
Dr. Fredrickson opened the meeting by briefly summarizing events 
concerning the revised NIH Guidelines for Recombinant DNA Research. He 
noted that the last meeting of the Interagency Committee was held in 
October to consider the NIH-proposed revision of July 1978. The final 
Guidelines were released in December 1978 and became effective on 
January 2, 1979. In their final form, the Guidelines specify, on the 
basis of Interagency Committee comments, an explicit role for the 
Committee, both as a group and as liaison members to the Recombinant DNA 
Molecule Program Advisory Committee (RAC). 
Dr. Fredrickson then introduced Dr. William Gartland, Director of 
the NIH Office of Recombinant DNA Activities (0RDA), and Dr. Richard 
Krause, Director of the National Institute of Allergy and Infectious 
Disease, where 0RDA is now located. 
[ 132 ] 
